|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.94 USD | -1.57% |
|
-10.31% | -14.36% |
| 05:18pm | Global markets live: Adidas, Mercedes, McDonalds, Eli Lilly, PayPal, MicroStrategy, Tesla... |  |
| 03:27pm | A flurry of corporate results ahead of the Fed's rate decision | |
Dec 15 (Reuters) - Bristol Myers Squibb said on Friday it would discontinue its late-stage trial testing a treatment for a type of colon cancer.
The company said an independent data monitoring committee's analysis showed the trial was unlikely to meet its primary endpoints upon completion.
The trial was evaluating a combination therapy in patients who received previous treatment for a kind of colorectal cancer.
(Reporting by Christy Santhosh; Editing by Maju Samuel and Shinjini Ganguli)
| 1st Jan change | Capi. | |
|---|---|---|
| -14.36% | 90.49B | |
| +34.00% | 664B | |
| +29.29% | 567B | |
| -7.75% | 354B | |
| +18.53% | 330B | |
| +4.95% | 286B | |
| +13.79% | 234B | |
| +4.93% | 199B | |
| -9.78% | 196B | |
| -4.89% | 148B |
BRISTOL-MYERS SQUIBB COMPANY 
